Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage (MODISH)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The goal in this research is to develop better ways to detect and treat the damage caused by bleeding in the brain.
| Condition |
|---|
|
Subarachnoid Hemorrhage |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage |
No specimens are to be retained.
| Estimated Enrollment: | 15 |
| Study Start Date: | June 2010 |
Patients who suffer from a bleeding in the brain (stroke or hemorrhage) often experience secondary complications that can occur up to 2 weeks after the initial bleeding. Complications can include decrease of consciousness, weakness or paralysis, difficulty with speech and language, and worsening of brain damage. These decrease a patient's chances for a good recovery. A brain scan will be used to determine the damage caused by the bleeding, and the brain's electrical activity will be monitored to detect abnormal activity. These measures will be analyzed together with routine medical information to better understand and diagnose complications.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients with subarachnoid hemmorhage clinical symptoms
Inclusion Criteria:
- Age 18 to 70 years
- World Federation of Neurosurgery (WFNS) grade III-IV, and grade V patients who improve within 24h after ventriculostomy
- Diffuse thick or localized thick subarachnoid clot >1 mm on baseline CT (Fisher grade 3-4)
- Ruptured saccular aneurysm demonstrated by CT-angiography or DSA
- Onset of aSAH clinical symptoms within the preceding 72h
- Treatment of aneurysm within 24 h after admission
- Treatment of aneurysm by clip ligation
Exclusion Criteria:
- SAH due to other causes (e.g. trauma, fusiform or mycotic aneurysm)
- Only a thin diffuse layer or no visible subarachnoid blood in the initial CT
- Admission in a clinical state with unfavourable prognosis (e.g., bilateral dilated, non-reactive pupils for more than 1h)
- Coagulopathy (thrombocytes <60,000/ml or INR>1.5)
- Pregnancy
- Presence of incompatibilities for MRI, such as non-removable metals, artificial joints, electronic devices (pace maker, pumps), etc.
Contacts and Locations| Contact: Carolyn Koenig, RN | (513) 558-3518 | carolyn.koenig@uc.edu |
| United States, Ohio | |
| University of Cincinnati | Recruiting |
| Cincinnati, Ohio, United States, 45219 | |
| Contact: Carolyn Koenig, RN 513-558-3518 carolyn.koenig@uc.edu | |
| Principal Investigator: | Jed Hartings, PhD | University of Cincinnati |
More Information
No publications provided
| Responsible Party: | Jed Hartings, Research Asst Professor, University of Cincinnati |
| ClinicalTrials.gov Identifier: | NCT01406457 History of Changes |
| Other Study ID Numbers: | 10-04-21-01 |
| Study First Received: | July 28, 2011 |
| Last Updated: | July 17, 2012 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by University of Cincinnati:
|
Subarachnoid Hemorrhage |
Additional relevant MeSH terms:
|
Hemorrhage Ischemia Subarachnoid Hemorrhage Pathologic Processes Intracranial Hemorrhages Cerebrovascular Disorders |
Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 23, 2013